Follow-up of benign results of stereotactic core breast biopsy

Validity of needle core biopsy in the histological characterisation of mammary lesions

“…This is the result not only of several years of study and work involving preclinical breast lesions, but also of extremely fruitful multidisciplinary cooperation in our Institute between radiologists, surgeons and pathologists. This fact concurs with recently published reports on the same subject by several other authors [1][2][3][4][5] and, furthermore, emphasises the fact that, in the last few years, experience with the use of CB has led to an increase in the diagnosis of ICs using this procedure, compared with the results published a few years ago, 3,6,8,10 when the rates of diagnosis of breast carcinomas using CB ranged from 8% to 42%.…”

“…1 Several published reports have demonstrated that in a high percentage of cases the histological results of CB concur with those obtained from the examination of the whole of the excised specimen. [3][4][5][6][7][8][9] Furthermore, CB provides an extremely high level of diagnostic reliability, not only with regard to cases of infiltrating carcinoma, but also to those involving atypical hyperplasia, lobular carcinomas in situ, [10][11][12][13][14][15][16] (DCIS) 4,5,8,11,14,16,17 and to a large number of benign breast diseases. 18,19 Although CB has not completely replaced traditional excisional biopsy, it is considered to be a valid diagnostic procedure, since it is not only efficient but also well tolerated and not particularly invasive, making it possible for the surgeon to provide the patient with a great deal of information regarding her disease and to plan a more specific therapeutic approach.…”

The use of fine-needle aspiration cytology and core biopsy in the assessment of highly suspicious mammographic microcalcifications

“…For programs largely reliant on core biopsy, the combined use of FNAB and core biopsy is advantageous in cases of nonrepresentative or false‐negative core biopsy results. This is estimated to be in the region of 1.2–20.5% in different series28–32 and was illustrated by finding unsuccessful core biopsy or inconclusive results in 13% of lesions in which core biopsy was performed after a positive cytologic diagnosis to assess the presence of stromal invasion. Had the lesion been assessed only by means of core biopsy, a definitive diagnosis of malignancy would not have been available in these tumors, necessitating recall of the patient for further investigation.…”

Accuracy of sonographically guided 14-gauge core-needle biopsy: Results of 715 consecutive breast biopsies with at least two-year follow-up of benign lesions

“…The false-negative rate in our study is comparable with the frequency of missed carcinoma on both prone stereotactic CNB and open needle-localized biopsy. [19][20][21][22] As in any percutaneous sampling procedure, there are potential pitfalls in CNB. 10 The radiologist performing the sonographically guided CNB should be aware of any technical difficulties that might result in inaccurate sampling.…”